Single-Cell Analysis: Global Strategic Business Report

Report
179 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 4805987

Global Single-Cell Analysis Market to Reach $25 Billion by 2030

The global market for Single-Cell Analysis estimated at US$6.4 Billion in the year 2022, is projected to reach a revised size of US$25 Billion by 2030, growing at a CAGR of 18.6% over the analysis period 2022-2030. Cancer, one of the segments analyzed in the report, is projected to record a 20.6% CAGR and reach US$10 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunology segment is readjusted to a revised 19.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 17.3% CAGR

The Single-Cell Analysis market in the U.S. is estimated at US$1.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 17.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 15.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.

Select Competitors (Total 11 Featured) -

Agilent Technologies, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Merck KgaA
Qiagen NV
Thermo Fisher Scientific, Inc.

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Single-Cell Analysis Techniques Market: Overview & Outlook
Single-Cell Analysis Techniques - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Single-Cell Analysis Techniques to Make Inroads in Cancer Care Programs
Soaring Cancer Research Investments Favor Market Expansion
Novel Opportunities for Single-Cell Analysis Techniques in IVF Domain
Pre-Implantation Genetic Diagnosis (PGD): A Growing Application Market
Relevance in EGG Health Analysis
Increased Focus on Personalized Medicine Augurs Well
Issues & Challenges

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Academic & Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Academic & Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Single-Cell Analysis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
Table 8: World Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 9: World Historic Review for Single-Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 10: World 16-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 11: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 12: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 13: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 16: World 16-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 19: World 16-Year Perspective for Stem Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Non-Invasive Prenatal Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for Non-Invasive Prenatal Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 29: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 30: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 31: World 16-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 34: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 35: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 36: USA Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 37: USA 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 38: USA Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 39: USA Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 40: USA 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

CANADA

Table 41: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 42: Canada Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 43: Canada 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 44: Canada Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 45: Canada Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 46: Canada 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

JAPAN

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 48: Japan Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 49: Japan 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 50: Japan Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 51: Japan Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 52: Japan 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

CHINA

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 53: China Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 54: China Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 55: China 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 56: China Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 57: China Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 58: China 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

EUROPE

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 59: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 60: Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 61: Europe 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 62: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 63: Europe Historic Review for Single-Cell Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 64: Europe 16-Year Perspective for Single-Cell Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 65: Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 66: Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 67: Europe 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

FRANCE

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 68: France Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 69: France Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 70: France 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 71: France Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 72: France Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 73: France 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

GERMANY

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 74: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 75: Germany Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 76: Germany 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 77: Germany Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 78: Germany Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 79: Germany 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

ITALY

Table 80: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 81: Italy Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 82: Italy 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 83: Italy Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 84: Italy Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 85: Italy 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

UNITED KINGDOM

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 86: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 87: UK Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 88: UK 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 89: UK Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 90: UK Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 91: UK 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 92: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 93: Rest of Europe Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 94: Rest of Europe 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 95: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 96: Rest of Europe Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 97: Rest of Europe 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Single-Cell Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 99: Asia-Pacific Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 100: Asia-Pacific 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 102: Asia-Pacific Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 103: Asia-Pacific 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

REST OF WORLD

Table 104: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 105: Rest of World Historic Review for Single-Cell Analysis by End-Use - Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 106: Rest of World 16-Year Perspective for Single-Cell Analysis by End-Use - Percentage Breakdown of Value Sales for Academic & Research Laboratories, Biotech & Pharma Companies, Hospitals & Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
Table 107: Rest of World Recent Past, Current & Future Analysis for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 108: Rest of World Historic Review for Single-Cell Analysis by Application - Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 109: Rest of World 16-Year Perspective for Single-Cell Analysis by Application - Percentage Breakdown of Value Sales for Cancer, Immunology, Stem Cell, Non-Invasive Prenatal Diagnosis, Neurology and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Agilent Technologies, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Merck KgaA
Qiagen NV
Thermo Fisher Scientific, Inc.

Table Information

Report Attribute	Details
No. of Pages	179
Published	April 2024
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 6.4 Billion
Forecasted Market Value ( USD ) by 2030	$ 25 Billion
Compound Annual Growth Rate	18.6%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5269EUR$5,450USD£4,526GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10011EUR$10,355USD£8,599GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15807EUR$16,350USD£13,577GBP

Global Single-Cell Analysis Market to Reach $25 Billion by 2030

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 17.3% CAGR

Select Competitors (Total 11 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Single-Cell Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Global Single-Cell Analysis Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Single-cell Analysis Global Market Report 2024

Single-cell Analysis Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Application (Cancer, Stem Cell, Neurology), By Workflow, By End Use, By Region, And Segment Forecasts, 2023-2030

Global Single Cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Forecast to 2028